1. Home
  2. CDNA vs ADTN Comparison

CDNA vs ADTN Comparison

Compare CDNA & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$22.86

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo ADTRAN Holdings Inc.

ADTN

ADTRAN Holdings Inc.

HOLD

Current Price

$16.68

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
ADTN
Founded
1998
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
CDNA
ADTN
Price
$22.86
$16.68
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$28.00
$15.50
AVG Volume (30 Days)
583.8K
2.7M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
90.83
EPS
0.05
N/A
Revenue
$48,324,000.00
$1,083,807,000.00
Revenue This Year
$16.01
$11.09
Revenue Next Year
$11.31
$8.47
P/E Ratio
$455.40
N/A
Revenue Growth
18.93
17.46
52 Week Low
$10.96
$7.11
52 Week High
$23.24
$19.98

Technical Indicators

Market Signals
Indicator
CDNA
ADTN
Relative Strength Index (RSI) 65.92 53.96
Support Level $15.80 $8.45
Resistance Level $22.89 $18.34
Average True Range (ATR) 0.95 1.14
MACD 0.11 0.15
Stochastic Oscillator 90.52 43.03

Price Performance

Historical Comparison
CDNA
ADTN

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.

Share on Social Networks: